A peer-reviewed study on voice AI and depression screening shows why demographic portability testing matters before deploying clinical AI tools.
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Why Research Sites Don't Use EMR As The Source Data Collection Tool
Examine the limitations of using Electronic Medical Records (EMRs) in clinical research compared to eSource systems.
-
Rewriting The Rules Of Clinical Trials Through Digital Biomarkers
Digital biomarkers are reshaping clinical research with continuous, real‑world data. Explore how emerging tools, AI, and cross‑industry collaboration are driving smarter clinical development.
-
Accelerating Site Activation: Examples From Novartis And IQVIA
As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.
-
Paper COAs In 2026? It's Not "Cheaper," It's Riskier
Paper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.
-
Reducing Supply Risk in Cell & Gene Therapy Trials
In cell and gene therapy trials, success depends on coordination. Learn how visibility, workflow control, and alignment help reduce risk and protect patient-specific treatments.
-
Don't Just Swap The Engine. Redesign The Factory.
Discover how AI-native technology is accelerating study startup, streamlining operations, and helping sponsors and CROs deliver therapies to patients faster.
-
Analyzing The FDA's Approach To Diversity In Clinical Trials
Learn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
-
3 Key Functions Your eTMF Needs To Meet New EMA Regulations
The European Union Clinical Trial Regulation No. 536/2014 recently introduced the most significant changes to the processes for clinical trial applications in at least the past 15 years. Learn how this impacts the Trial Master File and consider three key functions that an electronic TMF must have to achieve compliance and maintain organizational success.
-
Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch
The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.
-
How FAIR Data Principles Deliver Clinical Success
Prioritize data management that adheres to FAIR principles — findable, accessible, interoperable, and reusable — to gain operational insights that enable quick decisions and ensure participant well-being.
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
RECENT NEWSLETTERS
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution
- 07.16.26 -- Why Clinical Trial Sites Are Drowning In Tech Chaos